Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
2965 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 27 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2700 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
25 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-01-18 | 2021-02-05 | 131889 |
APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2021-01-18 | 2021-01-19 | 131886 |
APO PIROXICAM CAP 10MG | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-04-15 | 131883 |
APO-METHYLPHENIDATE SR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-02-10 | 131880 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-01-18 | 2021-02-26 | 131875 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-18 | 2021-03-09 | 131870 |
APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-18 | 2021-02-09 | 131815 |
APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-01-20 | 131809 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2021-01-08 | 2021-01-20 | 131176 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-09 | 131166 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-01-08 | 2021-03-01 | 131163 |
APO-FLECAINIDE | 50MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131160 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-01-08 | 2021-01-26 | 131157 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-08 | 2021-01-12 | 131154 |
APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131151 |
APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131148 |
APO-DASATINIB | 50MG | TABLET | Resolved | 2021-01-08 | 2021-03-17 | 131145 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-10 | 131142 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2021-01-04 | 2021-12-13 | 130810 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 |